(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二-1-萘基-4-氧化物二萘并[2,1-d:1',2'-f][1,3,2]二噁磷杂庚英 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
-
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二甲基-2-萘基-4-氧化物二萘并[2,1-d:1',2'-f][1,3,2]二噁磷杂庚英 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
ZMR-15-1379 | 100mg
-
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二-1-芘基-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-pyrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)
ZMR-15-0446 | 50mg
-
(11bR)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二-1-芘基-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-pyrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)
ZMR-15-0444 | 50mg
-
(11bR)-4-羟基-2,6-二-1-萘基-4-氧化物二萘并[2,1-d:1',2'-f][1,3,2]二噁磷杂庚英 (11bR)-4-Hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
ZMR-15-1388 | 100mg
-
(11bS)-2,6-二-9-蒽-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)
ZMR-15-0382 | 50mg
-
(11bS)-2,6-双[4-(2-萘基)苯基]-8,9,10,11,12,13,14,15-八氢-4-羟基-4-氧化物-二萘并[2,11-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-2,6-Bis[4-(2-naphthalenyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)
ZMR-15-0390 | 50mg
-
(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-双(三苯基)-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(triphenylsilyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
ZMR-15-0821 | 50mg
中文名称:(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二-1-萘基-4-氧化物二萘并[2,1-d:1',2'-f][1,3,2]二噁磷杂庚英
英文名称:(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
其他规格:25mg;分子式:C40H33O4P;分子量:608.7。
您正在浏览的产品:(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二-1-萘基-4-氧化物二萘并[2,1-d:1',2'-f][1,3,2]二噁磷杂庚英
手机版:(11bS)-8,9,10,11,12,13,14,15-八氢-4-羟基-2,6-二-1-萘基-4-氧化物二萘并[2,1-d:1',2'-f][1,3,2]二噁磷杂庚英
本公司销售的所有产品仅供实验科研使用,不用于人体及临床诊断。
2. 仪器条件:色谱柱温度为40℃,流速0.3 mL/min,质谱离子源为电喷雾电离(ESI),正离子模式扫描;
3. 数据采集:依据目标物母离子及碎片离子(如m/z 423.1→281.0)进行定量分析。
以上信息仅供参考,请以相应标准的原文为准!